Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001829126-25-008004
Filing Date
2025-10-09
Accepted
2025-10-09 17:29:55
Documents
1
Effectiveness Date
2025-10-09

Document Format Files

Seq Description Document Type Size
1 S-8 POS titanpharma_s8pos.htm S-8 POS 22837
  Complete submission text file 0001829126-25-008004.txt   23931
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-275153 | Film No.: 251385936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)